Sun Pharma Subsidiaries Settle US Generic Drug Pricing Antitrust Litigation
Sun Pharmaceutical Industries Ltd 路 Others (Uncategorized) 路 12 Sept 2026, 1:27 am
Sun Pharma Subsidiaries Settle US Generic Drug Pricing Antitrust Litigation Sun Pharmaceutical Industries Limited announced on 11th Sep'26 that its subsidiaries鈥擲un Pharmaceutical Industries, Inc., Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc.鈥攈ave executed a settlement agreement with a plaintiff in the *In re Generic Pharmaceuticals Pricing Antitrust Litigation* in the Eastern District of Pennsylvania, U.S. The settlement involves a confidential payout in exchange for a full release of all asserted claims against the entities and related parties, without any admission of wrongdoing. Other terms remain confidential.
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting 路 05 Nov 2026
- Q2FY27 Earnings Call Transcript 路 05 Nov 2026
- Clarification regarding news report relating to the Company''s Assam facility 路 03 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... 路 02 Nov 2026
- Completion and results of postal ballot dated 01 October 2026 路 01 Nov 2026
- Q2FY27- Investor Call Audio Recording 路 31 Oct 2026
- Board Meeting Outcome - Conclusion 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
